Article
Hybridization-Induced Aggregation Technology for Practical Clinical Testing: KRAS Mutation Detection in Lung and Colorectal Tumors.
The Journal of molecular diagnostics : JMD - 1 Jul 2016
Sloane Hillary S, Landers James P, Kelly Kimberly A
Abstract excerpt
KRAS mutations have emerged as powerful predictors of response to targeted therapies in the treatment of lung and colorectal cancers; thus, prospective KRAS genotyping is essential for appropriate treatment stratification. Conventional mutation testing technologies are not ideal for routine clinical screening, as they often involve complex, time-consuming processes and/or costly instrumentation. In response, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
